NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
20 December 2024
RECOMMENDED CASH OFFER
for
Aquis Exchange PLC ("Aquis")
by
SIX Exchange Group AG ("SIX")
to be effected by means of a scheme of arrangement under
Part 26 of the
RESULTS OF VOTING AT COURT MEETING AND GENERAL MEETING
On 11 November 2024, the boards of directors of Aquis and SIX announced that they had reached agreement on the terms of a recommended cash offer to be made by SIX for the entire issued and to be issued share capital of Aquis (the "Acquisition"), to be implemented by way of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act (the "Scheme").
On 27 November 2024, Aquis published a circular in relation to the Scheme (the "Scheme Document"). Capitalised terms used in this announcement shall, unless otherwise defined, have the meanings as set out in the Scheme Document.
Results of Court Meeting and General Meeting
Aquis is pleased to announce that, at the Court Meeting and General Meeting held earlier today in connection with the Acquisition:
(A) the requisite majorities of Scheme Shareholders voted in favour of the resolution to approve the Scheme at the Court Meeting; and
(B) the requisite majority of Aquis Shareholders voted in favour of the Special Resolutions to implement the Scheme, including the amendments to Aquis' articles of association, at the General Meeting.
Details of the resolutions proposed and passed are set out in the notices of the Court Meeting and the General Meeting contained in the Scheme Document.
Voting results of the Court Meeting
The table below sets out the results of the poll conducted at the Court Meeting. Each Scheme Shareholder present (including by proxy) was entitled to one vote per Scheme Share held at the Voting Record Time.
Results of Court Meeting |
Scheme Shares voted |
Scheme Shareholders who voted** |
No. of Scheme Shares voted as a % of Scheme Shares eligible to be voted at the Court Meeting* |
||
Number |
%* |
Number |
%* |
||
FOR |
21,545,887 |
99.97% |
33 |
100.00% |
78.06% |
AGAINST |
6,711 |
0.03% |
0 |
0.00% |
0.02% |
TOTAL |
21,552,598 |
100.00% |
33 |
100.00% |
78.08% |
*All percentages rounded to two decimal places.
** For the purposes of determining the number of Scheme Shareholders who voted as set out in this column, where a Scheme Shareholder cast some of their votes "for" and some of their votes "against" the resolution, such Scheme Shareholder has been counted as having voted in favour of the Scheme if they cast more votes 'for' the Scheme than 'against' the Scheme and otherwise, against.
Voting results of the General Meeting
The table below sets out the results of the poll conducted at the General Meeting. Each Aquis Shareholder present (including by proxy) was entitled to one vote per Aquis Share held at the Voting Record Time.
Special Resolutions |
Votes for** |
Votes against |
Total votes |
Withheld votes*** |
||
Number |
%* |
Number |
%* |
Number |
Number |
|
Effect the Scheme and amend the articles of association of Aquis |
20,851,390 |
99.97% |
5,598 |
0.03% |
20,856,988 |
1,113 |
Effect the re-registration of Aquis as a private limited company, subject to the Scheme becoming Effective |
20,851,390 |
99.97% |
5,598 |
0.03% |
20,856,988 |
1,113 |
*All percentages rounded to two decimal places.
**Includes discretionary votes.
***A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" the Special Resolutions.
The total number of Aquis Shares in issue at the Voting Record Time (at 6:30 p.m. (
Effective Date and Timetable
The outcome of today's Court Meeting and General Meeting means that Conditions 2(A) and 2(B) (as set out in Part III of the Scheme Document) have been satisfied. The Scheme remains subject to the satisfaction or (where applicable) waiver of the remaining Conditions and further terms set out in the Scheme Document, including the Court sanctioning the Scheme at the Sanction Hearing.
The expected timetable of principal events for the implementation of the Scheme remains as set out on pages xi and xii of the Scheme Document and as set out in the appendix below. The dates are indicative only and are subject to change. The dates will depend, among other things, on the dates upon which: (i) the Conditions are satisfied or (if capable of waiver) waived; (ii) the Court sanctions the Scheme; and (iii) the Court Order is delivered to the Registrar of Companies. If any of the dates and/or times in the expected timetable change, the revised dates and/or times will be notified by announcement through a Regulatory Information Service.
Enquiries
SIX |
|
Alain Bichsel |
+41 58 399 2675 |
|
|
UBS (Financial Adviser to SIX) |
+44 20756 78000 |
Sam Small |
|
Marco Superina |
|
Ben Crystal |
|
Florence Ho |
|
|
|
Brunswick (PR Adviser to SIX) |
|
Max McGahan |
+44 78345 02369 |
Simone Selzer |
+44 75151 87438 |
|
|
Aquis |
+44 (0) 20 3832 9933 |
Alasdair Haynes |
|
Richard Fisher |
|
Adele Gilbert |
|
|
|
Evercore (Lead Financial Adviser to Aquis) |
+44 (0)20 7653 6000 |
Ollie Clayton |
|
Ed Banks |
|
Max Fallstrom |
|
Harrison George |
|
|
|
Investec (NOMAD, Joint Broker & Joint Financial Adviser to Aquis) |
+44 (0) 20 7597 5970 |
David Anderson |
|
St John Hunter |
|
|
|
Canaccord Genuity (Joint Broker to Aquis) |
+44 (0) 20 7523 8000 |
Emma Gabriel |
|
George Grainger |
|
|
|
VSA Capital Limited (AQSE Corporate Adviser to Aquis) |
+44(0)20 3005 5000 |
Andrew Raca |
|
|
|
MHP Group (PR adviser to Aquis) |
+44 (0) 20 3128 8000 |
Eleni Menikou |
|
Robert Collett-Creedy |
|
|
|
Clifford Chance LLP is acting as legal adviser to SIX.
Slaughter and May is acting as legal adviser to Aquis.
APPENDIX
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
The following indicative timetable is based on Aquis' and SIX's current expected dates for the implementation of the Scheme and is subject to change. If any of the dates and/or times in this expected timetable change, the revised dates and/or times will be notified to Aquis Shareholders by announcement through the Regulatory Information Service of the LSE.
Event |
Time and date[1] |
Long Stop Date |
11 November 2025[2] |
The following dates are indicative only and are subject to change |
|
Sanction Hearing (to sanction the Scheme) |
A date expected to fall during Q2 2025, subject to the satisfaction (or, if applicable, waiver) of the relevant Conditions and, in any event, prior to the Long Stop Date ("D") * |
Last day of dealings in, and for the registration of transfers of, and disablement in CREST of, Aquis Shares |
D |
Scheme Record Time |
6:00 p.m. on D |
Effective Date |
D+1[3] |
Suspension of dealings in Aquis Shares on AIM and on the Aquis Stock Exchange |
by 7:30am on D+1 |
Cancellation of admission to trading of Aquis Shares on AIM and on the Aquis Stock Exchange |
at 7:00 a.m. on D+2* |
Latest date for dispatch of cheques, and crediting of CREST accounts due under the Scheme |
Within 14 days after the Effective Date |
* All dates by reference to "D" will be to the date falling the number of indicated Business Days immediately after date D, as indicated above.
Important notice
This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer to sell or subscribe for or any invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise.
The Acquisition shall be made solely by means of the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the offer document) which, together with the Forms of Proxy, contains the full terms and Conditions of the Acquisition.
This announcement has been prepared for the purpose of complying with English and Welsh law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside
This announcement does not constitute a prospectus or prospectus-equivalent document.
Disclaimers
UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in
Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the FCA in the
Investec Bank plc ("Investec"), which is authorised by the Prudential Regulation Authority and regulated in the
Canaccord Genuity Limited ("Canaccord Genuity"), which is authorised and regulated by the FCA in the
VSA Capital Limited ("VSA Capital"), which is authorised and regulated by the FCA in the
No person has been authorised to give any information or make any representations other than those contained in this announcement and, if given or made, such information or representations must not be relied upon as having been authorised by Aquis, the Aquis Directors, SIX, the SIX Directors or by UBS, Evercore, Investec, Canaccord Genuity or VSA Capital or any other person involved in the Acquisition. Neither the publication of this announcement nor holding the Meetings, the Scheme Court Hearing, or filing the Court Order shall, under any circumstances, create any implication that there has been no change in the affairs of the Aquis Group or the SIX Group since the date of this announcement or that the information in, or incorporated into, this announcement is correct as at any time subsequent to its date.
Overseas Shareholders
The availability of the Scheme and the Acquisition to Overseas Shareholders may be affected by the laws of the relevant jurisdictions in which they are resident. Overseas Shareholders should inform themselves of, and observe, any applicable requirements. It is the responsibility of all Overseas Shareholders to satisfy themselves as to the full compliance of the laws of the relevant jurisdiction in connection therewith, including the obtaining of any governmental, exchange control or other consents which may be required, or the compliance with other necessary formalities which are required to be observed and the payment of any issue, transfer or other taxes due in such jurisdiction.
The release, publication or distribution of this announcement in jurisdictions other than the
Unless otherwise determined by SIX or required by the Code, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from a Restricted Jurisdiction and persons receiving such (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdictions.
If the Acquisition is implemented by way of an Offer (unless otherwise permitted by applicable law and regulation), the Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Offer may not be capable of acceptance by any such use, means, instrumentality or facilities.
Additional information for US investors
The Acquisition relates to shares in a
Financial information included in this announcement has been or will have been prepared in accordance with accounting standards applicable in the
The receipt of cash pursuant to the Acquisition by a
It may be difficult for
Neither the United States Securities and Exchange Commission nor any
Forward looking statements
This announcement, oral statements made regarding the Acquisition, and other information published by Aquis, any member of the Aquis Group, SIX or the SIX Group contain statements which are, or may be deemed to be, "forward-looking statements". Such forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which Aquis, any member of the Aquis Group, SIX or the SIX Group shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements.
Forward-looking statements include, among other things, statements concerning the potential exposure of Aquis and the Aquis Group and SIX and the SIX Group to market risks, statements as to accretion and statements expressing management's expectations, beliefs, estimates, forecasts, projections and assumptions, including as to future potential cost savings, synergies, earnings, cash flow, return on capital employed, production and prospects. These forward-looking statements are identified by their use of terms and phrases such as "aims", "anticipate", "believe", "could", "estimate", "expect", "goals", "hopes", "intend", "may", "objectives", "outlook", "plan", "probably", "project", "risks", "seek", "should", "target", "will", "would" and similar terms and phrases.
By their very nature, forward-looking statements involve risks and uncertainties. There are a number of factors that could affect the future operations of SIX and the SIX Group and Aquis and the Aquis Group and could cause those results to differ materially from those expressed in the forward-looking statements included in this announcement. Neither Aquis, the Aquis Group, SIX nor the SIX Group, nor any of their respective associates or directors, officers or advisers, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. Given these risks and uncertainties, potential investors are cautioned not to place any reliance on these forward-looking statements.
The forward-looking statements contained in this announcement speak only as at the date of this announcement and are not intended to give any assurance as to future results. Other than in accordance with their legal or regulatory obligations, neither Aquis, the Aquis Group, SIX nor the SIX Group is under any obligation, and each such person expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Publication on a website
A copy of this announcement and the documents required to be published pursuant to Rule 26.3 of the Code, shall be made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Aquis and SIX's websites at https://www.aquis.eu/investors/offer-documentation and www.six-group.com/recommended-offer-aquis respectively by no later than 12 noon (
Rounding
Certain figures included in this announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.
[1] The dates and times are indicative only and are based on current expectations and may be subject to change and will depend on, among other things, the date on which the Conditions to the Scheme are satisfied or, if capable of waiver, waived, and the date on which the Court sanctions the Scheme. References to times are to
[2] This is the latest date by which the Scheme may become Effective. However, the Long Stop Date may be extended to such later date as (a) may be agreed in writing by Aquis and SIX, or (b) (in a competitive situation) as may be specified by SIX with the Panel's consent and Court approval (if such approval(s) are required).
[3] The Scheme shall become Effective as soon as a copy of the Court Order has been delivered to the Registrar of Companies. This is expected to occur following the Scheme Record Time and prior to the cancellation of trading in Aquis Shares. The events which are stated as occurring on subsequent dates are conditional on the Effective Date and operate by reference to that date.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.